Purpose of Screening
- Detecting antibodies that may attack fetal platelets.
- Reducing risks of internal or intracranial bleeding in newborns.
- Determining the need for early medical interventions during pregnancy.
Maternal Platelet Antibody Test | Lahalak Medical Platform
This specialized screening helps mothers with a history of neonatal thrombocytopenia assess risks in future pregnancies, ensuring a proactive treatment plan to protect the fetus from serious bleeding complications.
Scientific name: Maternal Platelet Antibody Screening (NAIT)
An advanced laboratory test measuring maternal antibodies against fetal platelet antigens, aiding in the diagnosis and management of neonatal alloimmune thrombocytopenia (NAIT) to prevent internal bleeding and ensure safety.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Venous blood sample collection
- Platelet antibody analysis
- Medical results report
Medical Service Information
Target Groups
- Mothers who previously had a baby with low platelets.
- Women with a family history of NAIT disease.
- Pregnant women suspected of having immune incompatibility.
Importance of Medical Follow-up
- Helps in developing a treatment plan involving IVIG.
- Determining the optimal delivery time for safety.
- Providing genetic counseling for future pregnancies.
Conditions & Notices
- Preferably bring medical reports of previous pregnancies
Medical services you might also like
